A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.

In the past two years, the Food and Drug Administration has approved two novel Alzheimer's therapies, based on data from ...

Researchers concluded that the GLP-1RA showed no ability to slow disease progression in people living with Parkinson’s ...

But it might even help you live longer, a new study found. You don’t even need to do anything drastic to reap the benefits. Here’s what researchers found, plus how to ramp up your own exercise ...

The study evaluates MRK’s pulmonary arterial hypertension (PAH) drug, Winrevair (sotatercept), for a more advanced version of the disease. This decision is based on strong efficacy data from ...

"External" causes like drug overdoses and homicide are killing young adults, but so are cardiometabolic diseases that previously mainly posed risks to older people. (Getty Creative) ...

"Most studies provided very low certainty evidence about the outcomes of interest, thus, we cannot exclude the possibility of benefit or harm," write the study authors. "All other published ...

On Jan. 20, 2025, my team published a study of more than 2.4 million people that evaluated the risks and benefits of GLP-1 drugs across 175 possible health outcomes. We found that these drugs ...

PARIS, France — A new study highlighted Monday the potential benefits of popular diabetes drugs on a wide range of health issues, including dementia and cardiovascular diseases, although experts ...

You may take Ozempic or another drug to control your diabetes or lose weight, but these so-called GLP-1s also have a host of other effects ‒ some good and some not so good. A new study ...

The study was published this week in the journal Nature Medicine. Advertisement With the drugs' novelty and soaring popularity, it's important for consumers to know about the effects on all organ ...